Health Condition 1: K639- Disease of intestine, unspecified Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Malotodextrin: Group ME- patient will receive 400 ml, 12 hours before surgery and 200 ml of Malotodextrin, 3 hours before surgery.
Control Intervention1: maltodextrin: Group E- patient
Sponsors
Dr. swati singh
Eligibility
Inclusion criteria
Inclusion criteria: Patients having Diabetes Mellitus Type 2 undergoing elective gastric surgery, colorectal surgery (CRS) with FBS less than 200 mg/dl and HbA1c less than 7 will be included. 2. Expected postoperative hospital stay of more than 72 h.
Exclusion criteria
Exclusion criteria: 1. patients undergoing emergency surgery or secondary surgery 2. patients with inability to receive enteral nutrition 3. patients with comorbidities to ensure the safety of the trial and minimize the occurrence of adverse events 4. patients with mental disorders, alcohol addiction, or drug abuse history 5. lactating and pregnant women 6. patients with allergy to maltodextrin and various drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is insulin resistance assessed by HOMA-IR on postoperative day 1.Timepoint: 24 hour after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes will be Perioperative glycemia, length of stay, fasting blood glucose, fasting insulin, insulin secretion index, insulin sensitivity index, intraoperative and post operative blood glucose upto 24 h post-surgery.Timepoint: upto 24 hours after surgery | — |
Countries
India
Contacts
Public ContactDr Swati Singh
Indira gandhi institute of medical sciences, patna
Outcome results
None listed